Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5274642
Max Phase: Preclinical
Molecular Formula: C23H17BrN6OS
Molecular Weight: 505.40
Associated Items:
ID: ALA5274642
Max Phase: Preclinical
Molecular Formula: C23H17BrN6OS
Molecular Weight: 505.40
Associated Items:
Canonical SMILES: CCn1cc(-c2cc(/N=C3/NC(=O)CS3)n(-c3ccc(C#N)cc3)n2)c2cc(Br)ccc21
Standard InChI: InChI=1S/C23H17BrN6OS/c1-2-29-12-18(17-9-15(24)5-8-20(17)29)19-10-21(26-23-27-22(31)13-32-23)30(28-19)16-6-3-14(11-25)4-7-16/h3-10,12H,2,13H2,1H3,(H,26,27,31)
Standard InChI Key: CHGADEKCSLVHEV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 505.40 | Molecular Weight (Monoisotopic): 504.0368 | AlogP: 5.00 | #Rotatable Bonds: 4 |
Polar Surface Area: 88.00 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.77 | CX LogP: 5.30 | CX LogD: 5.07 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -1.60 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):